Capital Flow Monitor · Sponsors · CIK 1994145
EnZeta Immunotherapies, Inc.
122 SEVILLA AVE # 919, CORAL GABLES, FL, 33134 · 9173644613
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$2.4M
Sold
$840K
% sold
35.4%
Investors
10
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-06 | D/A ·current | 506(b) | $2.4M | $840K | 35.4% | 10 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Paul Kelly — Executive Officer / Director, Coral Gables, FL
5 other raises
- Bain Capital Asia Direct Lending Private Investors (A), L.P. $57.3M of —
- Bain Capital Asia Direct Lending (B) (CTB), L.P. $0 of —
- Bain Capital Asia Direct Lending (A), L.P. $123.3M of —
- Bain Capital High Income Feeder, Ltd. $75K of —
- Bain Capital High Income Partnership, L.P. $4.08B of —
- Sergio Traversa — Director, Miami, FL
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.